Hongchang Price to Book Ratio 2013-2025 | HCIL
Historical price to book ratio values for Hongchang (HCIL) over the last 10 years. The current price to book ratio for Hongchang as of September 18, 2026 is 0.26.
| Hongchang Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 0.11 | 1.27 | |
| 2025-12-31 | 0.14 | $0.08 | 1.69 |
| 2025-09-30 | 0.08 | $0.08 | 1.00 |
| 2025-06-30 | 0.00 | $0.08 | 0.00 |
| 2025-03-31 | 0.17 | $0.08 | 2.13 |
| 2024-12-31 | 0.10 | 0.00 | |
| 2024-09-30 | 0.27 | $0.08 | 3.44 |
| 2024-06-30 | 0.20 | $0.08 | 2.64 |
| 2024-03-31 | 0.22 | $0.08 | 2.92 |
| 2023-12-31 | 0.35 | 0.00 | |
| 2023-09-30 | 0.50 | $0.08 | 6.61 |
| 2023-06-30 | 1.78 | $-0.02 | -82.03 |
| 2023-03-31 | 0.59 | $-0.02 | -28.64 |
| 2022-12-31 | 0.01 | 0.00 | |
| 2022-09-30 | 0.01 | $-0.02 | -0.62 |
| 2022-06-30 | 0.10 | $-0.02 | -5.36 |
| 2022-03-31 | 0.00 | $-0.02 | -0.17 |
| 2021-12-31 | 0.00 | 0.00 | |
| 2021-09-30 | 0.03 | $-0.02 | -1.75 |
| 2021-06-30 | 0.17 | $-0.02 | -9.88 |
| 2021-03-31 | 0.14 | $-0.02 | -8.65 |
| 2020-12-31 | 0.12 | 0.00 | |
| 2020-09-30 | 0.17 | $-0.01 | -16.83 |
| 2020-06-30 | 0.07 | $-0.01 | -8.02 |
| 2020-03-31 | 0.02 | $-0.01 | -1.93 |
| 2019-12-31 | 0.05 | 0.00 | |
| 2019-09-30 | 0.07 | $-0.01 | -11.75 |
| 2019-06-30 | 0.10 | $0.00 | -24.39 |
| 2019-03-31 | 0.21 | $0.00 | -75.00 |
| 2018-12-31 | 0.12 | 0.00 | |
| 2018-09-30 | 0.60 | $-0.01 | -117.65 |
| 2018-06-30 | 0.32 | $0.00 | -82.05 |
| 2018-03-31 | 0.25 | $-0.02 | -12.85 |
| 2017-12-31 | 0.74 | $-0.02 | -44.20 |
| 2017-09-30 | 0.21 | $-0.01 | -34.23 |
| 2017-06-30 | 0.20 | 0.00 | |
| 2017-03-31 | 0.27 | 0.00 | |
| 2016-12-31 | 0.47 | 0.00 | |
| 2016-09-30 | 0.05 | 0.00 | |
| 2016-06-30 | 0.03 | 0.00 | |
| 2016-03-31 | 0.07 | 0.00 | |
| 2015-12-31 | 0.37 | 0.00 | |
| 2015-06-30 | 0.60 | 0.00 | |
| 2015-03-31 | 1.25 | 0.00 | |
| 2014-12-31 | 0.96 | 0.00 | |
| 2014-09-30 | 0.79 | 0.00 | |
| 2014-06-30 | 0.79 | 0.00 | |
| 2014-03-31 | 0.93 | 0.00 | |
| 2013-12-31 | 0.78 | 0.00 | |
| 2013-06-30 | 1.26 | 0.00 | |
| 2013-03-31 | 0.65 | 0.00 | |
| 2012-09-30 | 0.46 | 0.00 | |
| 2012-06-30 | 0.74 | 0.00 | |
| 2010-09-30 | 6.26 | 0.00 | |
| 2010-06-30 | 5.11 | 0.00 | |
| 2010-03-31 | 5.80 | 0.00 | |
| 2009-12-31 | 3.29 | 0.00 | |
| 2009-09-30 | 10.67 | 0.00 | |
| 2009-06-30 | 6.38 | 0.00 | |
| 2009-03-31 | 1.39 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.055B | $0.003B |
| Hongchang International Co Ltd is a holding company mainly engaged in research and development and manufacture a medical product. Hongchang International Co Ltd, formerly known as Heyu Biological Technology Corp, is based in China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Boston Scientific (BSX) | United States | $63.114B | 13.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.977B | 11.11 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.225B | 41.21 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.822B | 22.82 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Omeros (OMER) | United States | $1.336B | 6.76 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.548B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.21 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |